期刊文献+
共找到431篇文章
< 1 2 22 >
每页显示 20 50 100
二甲双胍联合健脾方对脾虚型多囊卵巢综合征患者内分泌及生化指标的影响 被引量:12
1
作者 李伊莎 刘丹 詹惠珍 《海南医学》 CAS 2017年第22期3673-3675,共3页
目的探讨二甲双胍联合健脾方对脾虚型多囊卵巢综合征(PCOS)患者内分泌及生化指标的影响。方法选取黄石市中医医院妇科2014年1月至2016年12月期间收治的102例脾虚型PCOS患者为研究对象,根据随机数表法分为观察组和对照组,每组51例,对照... 目的探讨二甲双胍联合健脾方对脾虚型多囊卵巢综合征(PCOS)患者内分泌及生化指标的影响。方法选取黄石市中医医院妇科2014年1月至2016年12月期间收治的102例脾虚型PCOS患者为研究对象,根据随机数表法分为观察组和对照组,每组51例,对照组予二甲双胍治疗,观察组予二甲双胍联合健脾方治疗,疗程均为12周。比较两组患者治疗前后血清卵泡雌激素(FSH)、黄体生成素(LH)、催乳素(PRL)、雌二醇(E2)、睾酮(T)及甘油三酯(TG)、胆固醇(TC)及胰岛素抵抗指数(HOMA-IR)的变化。结果治疗后,观察组患者的血清LH、PRL、T、TC、TG及HOMA-IR分别为(8.64±1.13)U/L、(15.38±2.78)pmol/L、(1.93±0.52)nmol/L、(4.89±1.57)mmol/L、(1.51±0.53)mmol/L、(2.23±0.67),明显低于对照组的(10.14±1.24)U/L、(17.47±2.64)pmol/L、(2.30±0.59)nmol/L、(5.49±1.64)mmol/L、(1.79±0.65)mmol/L、(2.83±0.58),E2为(59.16±4.75)pmol/L,明显高于对照组的(54.12±4.38)pmol/L,差异均有统计学意义(P<0.05)。结论二甲双胍联合健脾方治疗脾虚型多囊卵巢综合征可以有效调节患者内分泌激素水平,改善脂代谢紊乱及胰岛素抵抗。 展开更多
关键词 多囊卵巢综合征 肥胖 二甲双胍 健脾方 脾虚
下载PDF
中药健脾法治疗特应性皮炎的Meta分析 被引量:8
2
作者 刘勇 赵一丁 闫小宁 《中国中药杂志》 CAS CSCD 北大核心 2018年第9期1922-1933,共12页
使用Meta分析探寻中药健脾法治疗特应性皮炎的临床疗效,计算机检索中国知网(CNKI)、万方数据知识服务平台、维普中文期刊数据库(VIP)、中国生物医学文献数据库(CBM),Pub Med,Cochrane Library,EMbase数据库,搜索中药健脾法治疗特... 使用Meta分析探寻中药健脾法治疗特应性皮炎的临床疗效,计算机检索中国知网(CNKI)、万方数据知识服务平台、维普中文期刊数据库(VIP)、中国生物医学文献数据库(CBM),Pub Med,Cochrane Library,EMbase数据库,搜索中药健脾法治疗特应性皮炎的随机对照试验,检索时限均为自建库至2017年12月,由2名评价员分别对检索出的文献进行筛选并提取有效数据,使用Cochrane推荐的偏倚风险评估方法评价纳入研究文献的偏倚风险,应用Review Manager 5.3软件进行Meta分析,最终纳入37项随机对照试验,共计2 973例患者。结果显示,中药健脾法与西药相比,临床有效率更高,差异具有统计学意义(OR=4.05,95%CI[3.27,5.03],P〈0.000 01);评分改善更加明显,包括SCORAD评分(WMD=-9.82,95%CI[-13.31,-6.33],P〈0.000 01)、EASI评分(WMD=-2.80,95%CI[-3.54,-2.07],P〈0.000 01)、瘙痒VAS评分(WMD=-0.79,95%CI[-1.10,-0.47],P〈0.000 01);血清生化水平改善更加明显,包括IFN-γ(WMD=1.75,95%CI[1.14,2.35],P〈0.000 01),IL-4(WMD=-3.15,95%CI[-4.16,-2.15],P〈0.000 01),EOS(WMD=-0.11,95%CI[-0.20,-0.02],P=0.02);复发率显著降低(OR=0.36,95%CI[0.21,0.60],P〈0.000 1);纳入研究中有11篇报告了试验相关不良反应。结果表明中药健脾法治疗特应性皮炎临床疗效明显高于西药组,另外由于所纳入的文献存在发表偏倚和低质量偏倚,此结论还需更多的多中心、高质量、大样本、双盲随机对照试验加以论证。 展开更多
关键词 特应性皮炎 中药健脾 META分析 系统评价
原文传递
Mechanism of Jianpi Qingchang Huashi Recipe in treating ulcerative colitis:A study based on network pharmacology and molecular docking 被引量:7
3
作者 Lie Zheng Xin-Li Wen Yan-Cheng Dai 《World Journal of Clinical Cases》 SCIE 2021年第26期7653-7670,共18页
BACKGROUND Ulcerative colitis(UC)is a refractory intestinal disease with alternating onset and remission and a long disease course,which seriously affects the health and quality of life of patients.The goal of treatme... BACKGROUND Ulcerative colitis(UC)is a refractory intestinal disease with alternating onset and remission and a long disease course,which seriously affects the health and quality of life of patients.The goal of treatment is to control clinical symptoms,induce and maintain remission,promote mucosal healing,and reduce recurrence.Clinical trials have shown unsatisfactory clinical response rates.As a supplementary alternative medicine,traditional Chinese medicine has a rich history and has shown good results in the treatment of UC.Because of the quality of herbal medicine and other factors,the curative effect of traditional Chinese medicine is not stable enough.The mechanism underlying the effect of Jianpi Qingchang Huashi Recipe(JPQCHSR)on inducing UC mucosal healing is not clear.AIM To investigate the potential mechanism of JPQCHSR for the treatment of UC based on network pharmacology and molecular docking.METHODS Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform was used to extract the active components and action targets of JPQCHSR,and the target names were standardized and corrected through UniProt database.The related targets of UC were obtained through GeneCards database,and the intersection targets of drugs and diseases were screened by jvenn online analysis tool.The visual regulatory network of"Traditional Chinese medicine-active components-target-disease"was constructed using Cytoscape software,the protein interaction network was constructed using STRING database,and enrichment analysis of gene ontology and Kyoto Encyclopedia of Genes and Genomes pathways was conducted through R software.At last,the active components were docked with the core target through SYBYL-X 2.1.1 software.RESULTS Through database analysis,a total of 181 active components,302 targets and 205 therapeutic targets were obtained for JPQCHSR.The key compounds include quercetin,luteolin,kaempferol,etc.The core targets involved STAT3,AKT1,TP53,MAPK1,MAPK3,JUN,TNF,etc.A total of 2861 items were obtained by GO en 展开更多
关键词 jianpi Qingchang Huashi recipe Ulcerative colitis Network pharmacology Molecular docking Inflammatory disease
下载PDF
Network pharmacology-based exploration of molecular mechanisms underlying therapeutic effects of Jianpi Huatan Quyu recipe on chronic heart failure with spleen Qi deficiency syndrome
4
作者 Si-Qi Li Dong-Yu Min +7 位作者 Jun-Wen Jiang Xiao-Ying Li Xu-Na Yang Wen-Bo Gu Jia-Hui Jiang Li-Hao Chen Han Nan Ze-Yu Chen 《World Journal of Cardiology》 2024年第7期422-435,共14页
BACKGROUND Chronic heart failure is a complex clinical syndrome.The Chinese herbal compound preparation Jianpi Huatan Quyu recipe has been used to treat chronic heart failure;however,the underlying molecular mechanism... BACKGROUND Chronic heart failure is a complex clinical syndrome.The Chinese herbal compound preparation Jianpi Huatan Quyu recipe has been used to treat chronic heart failure;however,the underlying molecular mechanism is still not clear.AIM To identify the effective active ingredients of Jianpi Huatan Quyu recipe and explore its molecular mechanism in the treatment of chronic heart failure.METHODS The effective active ingredients of eight herbs composing Jianpi Huatan Quyu recipe were identified using the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform.The target genes of chronic heart failure were searched in the Genecards database.The target proteins of active ingredients were mapped to chronic heart failure target genes to obtain the common drugdisease targets,which were then used to construct a key chemical componenttarget network using Cytoscape 3.7.2 software.The protein-protein interaction network was constructed using the String database.Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were performed through the Metascape database.Finally,our previously published relevant articles were searched to verify the results obtained via network pharmacology.RESULTS A total of 227 effective active ingredients for Jianpi Huatan Quyu recipe were identified,of which quercetin,kaempferol,7-methoxy-2-methyl isoflavone,formononetin,and isorhamnetin may be key active ingredients and involved in the therapeutic effects of TCM by acting on STAT3,MAPK3,AKT1,JUN,MAPK1,TP53,TNF,HSP90AA1,p65,MAPK8,MAPK14,IL6,EGFR,EDN1,FOS,and other proteins.The pathways identified by KEGG enrichment analysis include pathways in cancer,IL-17 signaling pathway,PI3K-Akt signaling pathway,HIF-1 signaling pathway,calcium signaling pathway,cAMP signaling pathway,NF-kappaB signaling pathway,AMPK signaling pathway,etc.Previous studies on Jianpi Huatan Quyu recipe suggested that this Chinese compound preparation can regulate the TNF-α,IL-6,MAPK,cAMP,and AMPK pathways to affect the mitochond 展开更多
关键词 jianpi Huatan Quyu recipe Traditional Chinese medicine Chronic heart failure Data mining Network pharmacology BIOINFORMATICS Spleen Qi deficiency syndrome
下载PDF
Jianpi Bushen Recipe affects epithelial-mesenchymal transition in hepatocellular carcinoma through TGF-β and Twist 被引量:1
5
作者 Hong-Jie Liu You—Ying Lai +2 位作者 Zhi-Fen Han Jian-Jie Chen Xin-Wen Ma 《Drug Combination Therapy》 2020年第1期1-6,共6页
Backgroud:To explore the effects of Jianpi Bushen Recipe on the epithelial-mesenchymal transition(EMT)of nude mice with transplanted human liver cancer SK-HEP-1 cells.Methods:To establish models with transplanted live... Backgroud:To explore the effects of Jianpi Bushen Recipe on the epithelial-mesenchymal transition(EMT)of nude mice with transplanted human liver cancer SK-HEP-1 cells.Methods:To establish models with transplanted liver cancer cells,nude mice were divided randomly into three groups:blank group,traditional Chinese medicine(TCM)group and control group.They were given normal saline,Jianpi Bushen Recipe and solafeni through administration by gavage for four weeks.The expression of TGF-β and twist mRNA were detected by real-time PCR.The expression of E-cadherin was detected by Western blot.Results:Compared with the blank group,the expression of transforming growth factor-P(TGF-β)mRNA and twist mRNA in the TCM group and the control group decreased significantly(P<0.05).There was no significant difference between the two groups(P>0.05).The expression of E-cadherin protein in TCM group and control group increased significantly(P<0.01).There was no significant difference between the two groups(P>0.05).Conclusion:Jianpi Bushen Recipe can inhibit the EMT of liver cancer SK-HEP-1 cells in vivo by down-regulating the expression of TGF-β/twist signaling and indirectly up-regulating E-cadherin expression in transplanted liver cancer tissue,indicating the potential of Jianpi Bushen Recipe to inhibit invasion and metastasis of liver cancer. 展开更多
关键词 jianpi Bushen recipe Liver cancer Epithelial-mesenchymal transition TGF-Β TWIST E-CADHERIN
下载PDF
Efficacy of Jianpi Bushen Huatan Recipe in the treatment of obese polycystic ovarian syndrome:A meta-analysis
6
作者 Lin Huang Xiao-Bin Li Yun-Yun Luo 《Journal of Hainan Medical University》 2021年第5期44-48,共5页
Objective:To evaluate the effects of Jianpi Bushen Huatan Recipe on sex hormone levels、blood lipid and blood glucose levels in the treatment of obese poly-cystic ovarian syndrome(PCOS).Methods:Data bases including th... Objective:To evaluate the effects of Jianpi Bushen Huatan Recipe on sex hormone levels、blood lipid and blood glucose levels in the treatment of obese poly-cystic ovarian syndrome(PCOS).Methods:Data bases including the CNKI、Vip、Wanfang were searched.Studies about randomized controlled trials(RCT)of the effectiveness of Jianpi Bushen Huatan Recipe Combined with Metformin in the Treatment of obese PCOS were included.Rev Man 5.3 software was used for meta analysis.Results:A total of 11 studies were enrolled.Meta-analysis showed that Jianpi Bushen Huatan Recipe Combined with Metformin significantly improved the clinical total effective rate of patien ts(RR=1.32,95%CI(1.20,1.45),P<0.00001);reduced the body mass index(BMI)(SMD=-0.92,95%CI(-1.13,-0.72),P<0.00001),luteinizing hormone(LH)(SMD=-1.00,95%CI(-1.37,-0.62),P<0.00001),LH/FSH(SMD=-1.03,95%CI(-1.34,-0.71),P<0.00001),insulin resistant index(HOMA-IR)(SMD=-0.59,95%CI(-0.79,-0.40),P<0.00001),fasting insulin(FIN)(SMD=-0.77,95%CI(-1.19,-0.35),P=0.0003),total cholesterol(TC)(SMD=-0.63,95%CI(-0.88,-0.38),P<0.00001),triglycerides(TG)(SMD=-0.60,95%CI(-0.83,-0.36),P<0.00001),highdensity lipoprotein(HDL)(SMD=-0.41,95%CI(-0.51,-0.32),P<0.00001).However,there was no statistically significant in waist-to-hip ratio(WHR),follicle stimulating hormone(FSH),fasting blood sugar(FBS)and low density lipoprotein(LDL).Conclusions:Jianpi Bushen Huatan Recipe Combined with Metformin in the treatment of obese PCOS has an advantage in improving the sex hormone level,blood lipid and blood glucose level,and is superior to metformin alone. 展开更多
关键词 OBESE Polycystic ovarian syndrome METFORMIN jianpi Bushen Huatan recipe META-ANALYSIS
下载PDF
Analyzing the effective compounds, potential targets and diseases of Jianpi Jiedu recipe based on network pharmacology and function validation of cytobiology
7
作者 Xue-Qing Hu Ru Jia +5 位作者 Xuan Liu Qin Song Hui-Rong Zhu Qi Li Qing Ji Yu Feng 《TMR Cancer》 2019年第1期127-132,共6页
Objective: To analyze the active compounds, potential drug targets and therapy diseases of Jianpi Jiedu Recipe (JPJDR) based on network pharmacology and bioinformatics technology, and verify the biological function of... Objective: To analyze the active compounds, potential drug targets and therapy diseases of Jianpi Jiedu Recipe (JPJDR) based on network pharmacology and bioinformatics technology, and verify the biological function of some active compounds by cytology experiments. Methods: The online databases including TCMSP, TCMID, Cancer HSP, TCM-PTD, TCM Database@Taiwan and DrugBank were applied to screen the active compounds and the potential drug targets of JPJDR. Cytoscape 3.3 software was executed to construct the network between active compounds and drug targets. DAVID database was used to probe the effective diseases and analyze the involved KEGG pathways according to the predicted targets corresponding to JPJDR. Results: According to the rules of oral bioavailability (OB)>30% and drug-likeness (DL)>0.18, 58 of 513 effective compounds in JPJDR were screened out, as well as the corresponding 437 potential drug targets. By the analysis of DAVID database, all these key targets were associated closely with the occurrence and development of metabolic disorders and cancers, and all the targets were closely correlated with the pathways in cancer. Further analysis demonstrated that, there were a lot of effective compounds in JPJDR, such as Quercetin, Formononetin, Stigmasterol, Diosgenin,β-sitsterol, Oxymatrine, Kaempferol, Isorhamnetin and Ampelopsis. The results of cell proliferation experiments further showed that, among the selected nine key traditional Chinese medicine compounds, only Ampelopsis can dose-dependently inhibit the proliferation of colorectal cancer cells. Conclusions: Through network pharmacology analysis, we found that JPJDR contains many effective compounds which may directly target to the cancer-related proteins. 9 compounds were the major active compounds with high degrees of targets. Among the 9 screened compounds, Ampelopsis was validated for its inhibitory effect on the proliferation of colorectal cancer cells using CCK-8 assay. Network pharmacology is an effective approach to explore the functional m 展开更多
关键词 EFFECTIVE compound DRUG target Function validation jianpi Jiedu recipe Network PHARMACOLOGY
下载PDF
Wenshen Jianpi recipe(温肾健脾方) induced immune reconstruction and redistribution of natural killer cell subsets in immunological non-responders of human immunodeficiency virus/acquired immune deficiency syndrome:a randomized controlled trial
8
作者 TAO Zhuang WANG Jian +5 位作者 CHEN Xin LI Yonghong YAN Yuguang ZHANG Ao ZOU Wen LIU Ying 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2022年第5期795-802,共8页
OBJECTIVE:To evaluate the effects of the Wenshen Jianpi recipe(温肾健脾方,WJR)on immune reconstruction and natural killer(NK)cells in immunological non-responders(INRs)of people living with human immunodeficiency viru... OBJECTIVE:To evaluate the effects of the Wenshen Jianpi recipe(温肾健脾方,WJR)on immune reconstruction and natural killer(NK)cells in immunological non-responders(INRs)of people living with human immunodeficiency virus(HIV)(PLWH)and propose new therapeutic strategies for HIV.METHODS:Based on Traditional Chinese Medicine treatment principle“invigorating Qi and warming Yang in the spleen and kidneys”,WJR combined with antiretroviral therapy(ART)therapy was performed in a randomized,double-blind,placebo-controlled study of 60 patients with non-responders.The randomized process was executed by the Clinical Evaluation Center of China Academy of Chinese Medical Sciences.Sixty patients who met the inclusion criteria obtained random numbers(that is the drug number)was randomly divided into a treatment group and a placebo control group according to a 1∶1 ratio.CD4+T cell counts and natural killer(NK)cells counts were evaluated at baseline and 12-week,24-week follow-ups.RESULTS:Four participants received random numbers and did not enter the group due to the patient’s own reasons.A total of 56 patients were enrolled,including 28 in the treatment group and 28 in the control group.CD4+T cell counts in the treatment group were significantly increased at week 24(P=0.01<0.05),which were significantly higher than those in the control group(P=0.01<0.05).Although no significant differences were observed between two groups,the CD56bri CD16-NK cell counts in the treatment group were significantly increased after duration.and CD56dim CD16+NK cell counts in the treatment group were significantly higher than those in the control group after 24 weeks of treatment(P=0.025<0.05).As compared with the control group,the treatment group had significantly lower CD56neg CD16+NK cell counts after 24 weeks of treatment(P=0.023<0.05).CONCLUSIONS:WJR promotes the immune reconstruction of INRs and redistribution of NK cell subsets,notably decreasing CD56neg CD16+NK cell counts in INRs.However,the redistribution of NK cell subsets is not 展开更多
关键词 HIV acquired immunodeficiency syndrome killer cells natural immunological non-responders antiretroviral therapy Wenshen jianpi recipe immune reconstruction randomized controlled trial
原文传递
益肺健脾方对慢性阻塞性肺疾病患者痰液炎症细胞计数和IL-8、TNF-α水平的影响 被引量:41
9
作者 王胜 季红燕 +5 位作者 张念志 卓秀珍 赵丽萍 朱慧志 陈炜 任薇 《中国中西医结合杂志》 CAS CSCD 北大核心 2005年第2期111-113,共3页
目的 探讨益肺健脾方对慢性阻塞性肺疾病(COPD)的作用及其机制。方法 将40例稳定期COPD患者随机分为治疗组和对照组,观察其治疗前后痰液炎症细胞计数与分类、白细胞介素8(IL-8)、肿瘤坏死因子α(TNF-α)、1秒钟用力呼气容积占预计值百分... 目的 探讨益肺健脾方对慢性阻塞性肺疾病(COPD)的作用及其机制。方法 将40例稳定期COPD患者随机分为治疗组和对照组,观察其治疗前后痰液炎症细胞计数与分类、白细胞介素8(IL-8)、肿瘤坏死因子α(TNF-α)、1秒钟用力呼气容积占预计值百分比(FEV1占预计值%)、1秒钟用力呼气容积/用力肺活量(FEV1/FVC)等指标变化,并与20名健康人作比较。结果 COPD患者治疗前后各指标与健康人比较差异均有显著性(P<0.01)。治疗后治疗组痰液中性粒细胞(PMN)、IL-8和TNF-α水平较治疗前显著降低(P<0.01),非中性粒细胞(nPMN)、FEV1占预计值%和FEV1/FVC显著升高(P<0.01);对照组仅FEV1占预计值%和FEV1/FVC明显升高(P<0.05,P<0.01)。治疗组降低PMN、IL-8和TNF-α水平,升高nPMN、FEV1占预计值%和FEV1/FVC的作用显著优于对照组(P<0.01)。结论 益肺健脾方可减轻COPD患者气道炎症反应而发挥治疗作用。 展开更多
关键词 IL-8 FEV1/FVC 益肺健脾 痰液 PMN 炎症细胞 COPD患者 水平 结论 用力
下载PDF
补肾健脾方对原发性肝癌介入术后患者细胞免疫功能的调节作用 被引量:39
10
作者 王文海 周荣耀 +5 位作者 颜志平 林均华 叶正宝 吴达明 吴丽英 吴海良 《中国中西医结合杂志》 CAS CSCD 北大核心 2008年第7期583-587,共5页
目的观察补肾健脾方对原发性肝癌介入术后中医辨证属肝肾阴虚兼脾气虚型患者细胞免疫功能的调节作用。方法采用多中心随机对照原则,将117例患者分为治疗组60例、对照组57例。治疗组肝动脉化疗栓塞(TACE)术后服补肾健脾方12周,对照组术... 目的观察补肾健脾方对原发性肝癌介入术后中医辨证属肝肾阴虚兼脾气虚型患者细胞免疫功能的调节作用。方法采用多中心随机对照原则,将117例患者分为治疗组60例、对照组57例。治疗组肝动脉化疗栓塞(TACE)术后服补肾健脾方12周,对照组术后服保肝药(水飞蓟素与维生素C)12周。观察患者临床中医证候疗效、生活质量、瘤体近期疗效、生存期及细胞免疫功能〔3H掺入法检测T淋巴细胞增殖,流式细胞仪检测单核细胞表面MHCⅠ/Ⅱ类分子及B7分子表达,酶联免疫吸附法(ELISA)检测细胞因子IL-10、干扰素-γ(IFN-γ)、IL-12〕。结果服用补肾健脾方可明显提高中医证候疗效(73.33%,44/60例),对照组为52.63%(30/57例);提高0.5年生存率(83.33%,50/60例),对照组为70.18%(40/57例);两组比较,差异均有统计学意义(P<0.05);提高患者生活质量,无明显不良反应。但对照组疾病控制率92.7%(CR+PR+SD,51/55例)高于治疗组(78.0%,46/59例),P=0.035;治疗组单核细胞表面MHCⅡ类分子(CD14+/HLA-DR)表达提高,IFN-γ及IL-12的表达提高。结论补肾健脾方与介入术同用可增强患者细胞免疫功能,对提高原发性肝癌临床疗效有一定作用。 展开更多
关键词 补肾健脾方 原发性肝癌 肝动脉化疗栓塞 HLA—DR 细胞因子
下载PDF
补肺健脾方对慢性阻塞性肺疾病大鼠膈神经放电和膈肌功能的影响 被引量:36
11
作者 李素云 李亚 +4 位作者 李建生 邓丽 田燕歌 姜素丽 王英 《中国中西医结合杂志》 CAS CSCD 北大核心 2012年第6期812-816,共5页
目的观察补肺健脾方对慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)稳定期大鼠膈神经放电和膈肌功能的影响。方法将大鼠随机分为正常对照组、模型组、补肺健脾高、中、低剂量[9.68、4.84、2.42g/(kg·d)]组和氨... 目的观察补肺健脾方对慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)稳定期大鼠膈神经放电和膈肌功能的影响。方法将大鼠随机分为正常对照组、模型组、补肺健脾高、中、低剂量[9.68、4.84、2.42g/(kg·d)]组和氨茶碱组[2.3mg/(kg·d)],采用香烟熏吸联合细菌感染法制作COPD稳定期模型。于第9周起分别给予高、中、低剂量补肺健脾方和氨茶碱至第20周取材,观察肺功能、膈神经放电时间(di-aphragmatic neural discharge time,Td)、间期(diaphragmatic neural discharge interval,Tdi)、幅度(diaphragmaticneural discharge range,Rd)、面积(diaphragmatic neural discharge area,Ad)、吸气时间(inspiratory time,Tin)和呼气时间(expiratory time,Tex)、呼吸频率(respiratory rate,RR)、幅度(respiratory excursion,RE)和面积(respiratoryarea,RA)、膈肌张力及耐力等。结果与正常对照组比较,模型组潮气量(tidal volume,TV)、呼气峰流速(peakexpiratory flow,PEF)和50%潮气量呼气流速(50%tidal volume expiratory flow,EF50)显著降低(P<0.01),Td、Tdi、Tin和Tex显著延长(P<0.05,P<0.01),Rd和Ad、RR、RE和RA、离体膈肌张力与耐力均明显降低(P<0.05,P<0.01),膈肌Ⅰ、ⅡA型纤维比例显著增加(P<0.01),ⅡB型纤维比例显著减少(P<0.01),三磷酸腺苷(a-denosine triphosphate,ATP)酶活性降低而琥珀酸脱氢酶(succinate dehydrogenase,SDH)活性升高(P<0.01)。补肺健脾组上述指标均不同程度改善,尤以高、中剂量组改善较为明显(P<0.05,P<0.01),部分指标疗效优于氨茶碱。结论补肺健脾方可以显著改善COPD大鼠膈神经放电和膈肌功能。 展开更多
关键词 补肺健脾方 慢性阻塞性肺疾病 膈神经放电 膈肌功能
下载PDF
补肾健脾方联合地屈孕酮对早期先兆流产的疗效及妊娠结局的影响 被引量:35
12
作者 侯秀红 胡晓梅 《海南医学》 CAS 2020年第2期211-213,共3页
目的研究补肾健脾方联合地屈孕酮对早期先兆流产的疗效及妊娠结局的影响,为患者的临床治疗提供指导。方法回顾性分析金山区中西医结合医院妇产科2016年5月至2018年5月接诊的60例早期先兆流产患者的临床资料,根据治疗方法不同分为观察组... 目的研究补肾健脾方联合地屈孕酮对早期先兆流产的疗效及妊娠结局的影响,为患者的临床治疗提供指导。方法回顾性分析金山区中西医结合医院妇产科2016年5月至2018年5月接诊的60例早期先兆流产患者的临床资料,根据治疗方法不同分为观察组和对照组,每组30例。对照组给予地屈孕酮治疗,观察组给予补肾健脾方联合地屈孕酮治疗。1周为1个疗程,治疗4个疗程。4个疗程后,比较两组患者治疗后的临床疗效,治疗前后的β-绒毛膜促性腺激素(β-HCG)和孕酮水平,以及妊娠结局和不良反应发生情况。结果治疗后,观察组患者的治疗总有效率为93.33%,明显高于对照组的70.00%,差异有统计学意义(P<0.05);治疗前,两组患者的β-HCG、孕酮水平比较差异均无统计学意义(P>0.05);治疗后,观察组患者的孕酮和β-HCG水平分别为(38.73±5.64)ng/mL、(17645.41±2453.36)U/L,明显高于对照组的(30.36±3.87)g/mL、(14552.34±1633.28)U/L,差异均有统计学意义(P<0.05);观察组患者足月妊娠率为86.67%,明显高于对照组的60.00%,流产率为6.67%,明显低于对照组的26.67%,差异均有统计学意义(P<0.05);观察组患者的不良反应总发生率为13.33%,对照组为10.00%,差异无统计学意义(P>0.05)。结论早期先兆流产患者采用补肾健脾方联合地屈孕酮治疗可有效改善患者内分泌激素水平,妊娠结局较好,且不会增加不良反应。 展开更多
关键词 先兆流产 补肾健脾方 地屈孕酮 早期 疗效 妊娠结局
下载PDF
健脾疏肝方治疗非酒精性脂肪性肝炎多中心、随机、对照的临床研究 被引量:35
13
作者 李军祥 王允亮 +12 位作者 刘敏 刘绍能 徐春军 赵晶 史瑞 苏冬梅 诸葛丽 陈希 余轶群 李立 谢春娥 胡立明 张厂 《中国中西医结合杂志》 CAS CSCD 北大核心 2014年第1期15-19,共5页
目的从肝脏酶学(ALT)、影像学(肝/脾CT比值)及证候评分等多方面对中医干预非酒精性脂肪性肝炎(non-alcoholic steatohepatitis,NASH)病证结合临床治疗方案的有效性及安全性进行综合评价。方法采用多中心、分层随机、平行对照、盲法评价... 目的从肝脏酶学(ALT)、影像学(肝/脾CT比值)及证候评分等多方面对中医干预非酒精性脂肪性肝炎(non-alcoholic steatohepatitis,NASH)病证结合临床治疗方案的有效性及安全性进行综合评价。方法采用多中心、分层随机、平行对照、盲法评价、优效性试验设计,204例患者分别采用中药(试验组,102例)和西药(对照组,102例)治疗,观察ALT水平,腹部CT肝/脾比值,临床症状等。结果全国4家医院实际进入随机化分配的204例,剔除3例,脱落25例,符合方案并随访完整的共176例。3个月治疗结束后,中药组在证候评分以及部分症状(神疲乏力、面色萎黄)的改善方面优于对照组(P<0.05);随访3个月后,中药组在证候评分及部分症状(神疲乏力、面色萎黄)的改善方面优于对照组(P<0.05);两组在改善肝脏酶学、肝/脾CT比值方面差异无统计学意义(P>0.05)。两组共发生4例不良反应/不良事件,主要为药物性肝损害、腹泻、胃脘部不适,差异无统计学意义,与中医治疗方案无关。结论中药健脾疏肝方对于治疗NASH具有一定的疗效,健脾疏肝方可以消除肝脏脂肪,并起到保肝抗炎的作用,能有效改善ALT水平,肝/脾CT比值,在改善临床症状方面优于西药易善复,尤其对神疲乏力、面色萎黄等症状疗效明显。 展开更多
关键词 健脾疏肝方 非酒精性脂肪性肝炎 中医治疗方案
原文传递
益肺健脾方对慢性阻塞性肺疾病模型大鼠气道炎症和气道黏液高分泌的影响 被引量:34
14
作者 王胜 熊玲玲 +3 位作者 任薇 朱春冬 李春颖 周群 《中国中西医结合杂志》 CAS CSCD 北大核心 2015年第8期993-999,共7页
目的观察益肺健脾方对慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)模型大鼠的防治作用,从气道炎症和气道黏液高分泌角度探讨其作用机制。方法采用烟熏和大鼠气管内注入脂多糖(lipopolysaccharide,LPS)的方法建立COP... 目的观察益肺健脾方对慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)模型大鼠的防治作用,从气道炎症和气道黏液高分泌角度探讨其作用机制。方法采用烟熏和大鼠气管内注入脂多糖(lipopolysaccharide,LPS)的方法建立COPD模型。将雄性SD大鼠随机分为空白对照组(对照组)、模型组、益肺健脾方组(中药组),每组6只。采用肺功能仪检测大鼠用力肺活量(forced vital capacity,FVC)、0.1秒用力呼气容积(forced expiratory volume in 0.1 second,FEV0.1)、FEV0.1/FVC、呼气峰值流速(peak expiratory flow,PEF),HE染色观察大鼠支气管、肺组织病理变化。采用阿尔辛蓝-过碘酸雪夫(AB-PAS)染色观察气道杯状细胞。采用ELISA法检测各组大鼠支气管肺泡灌洗液(bronchoalveolar lavage fluid,BALF)中IL-8、IL-17及TNF-α的含量。采用免疫组织化学法检测大鼠气道中黏附分子1(intercellular cell adhesion molecule-1,ICAM-1)、核因子κB(nuclear factor-κb,NF-κB)、黏蛋白5AC(mucin 5AC,Muc5AC)和T0ll样受体4(Toll-like receptor 4,TLR4)蛋白的表达。采用实时荧光定量PCR(real-time quantitative PCR,real-time qPCR)检测支气管肺组织中Muc5AC和TLR4 mRNA的表达。结果模型组大鼠支气管、肺组织改变符合COPD病理表现。与模型组比较,中药组肺损伤程度减轻。与对照组比较,模型组FVC、FEV0.1、FEV0.1/FVC、PEF降低(P<0.01),BALF中IL-8、IL-17和TNF-α含量升高(P<0.01),支气管肺组织中ICAM-1、NF-κB、Muc5AC蛋白、TLR4蛋白、Muc5AC mRNA及TLR4 mRNA表达水平升高(P<0.01)。与模型组比较,中药组FVC、FEV0.1、FEV0.1/FVC、PEF升高(P<0.01,P<0.05),其余各指标均降低(P<0.01,P<0.05)。结论益肺健脾方可降低COPD模型大鼠BALF中IL-8、IL-17、TNF-α水平,抑制气道和肺组织内ICAM-1、NF-κB、Muc5AC和TLR4蛋白的表达,通过减轻气道炎症和气道黏液高分泌作用达到防治COPD目的。 展开更多
关键词 慢性阻塞性肺疾病 益肺健脾方 气道炎症 气道黏液高分泌
原文传递
补肾健脾活血方对去卵巢大鼠骨转换主要生化指标的影响 被引量:27
15
作者 胡冰 杨述华 +1 位作者 邱幸凡 张六通 《湖北中医学院学报》 2003年第1期20-22,共3页
目的 :观察补肾健脾活血方对绝经后骨质疏松症患者骨转换主要生化标志物的影响。方法 :选用 6月龄SD雌性大鼠 84只 ,随机分成正常组、假手术组、模型组、中药对照组、西药对照组、补肾健脾活血方大、小剂量组共 7组 ,用卵巢切除的方法... 目的 :观察补肾健脾活血方对绝经后骨质疏松症患者骨转换主要生化标志物的影响。方法 :选用 6月龄SD雌性大鼠 84只 ,随机分成正常组、假手术组、模型组、中药对照组、西药对照组、补肾健脾活血方大、小剂量组共 7组 ,用卵巢切除的方法进行动物造模 ,给药 90天后检测血清E2 、BGP和尿DPD等指标进行观察。结果 :补肾健脾活血方能明显增加血清E2 、BGP的含量 ,降低尿DPD含量 (P <0 0 1) ,其作用显著优越于西药雌激素治疗 ,且与剂量呈正相关。结论 :补肾健脾活血方能促进骨形成。 展开更多
关键词 补肾健脾活血方 绝经后骨质疏松症 实验研究 中药 药理
下载PDF
健脾益气方对急性胃粘膜损伤大鼠热休克蛋白的影响 被引量:25
16
作者 李国成 罗树星 +2 位作者 黄燏 陈训武 邱绮玉 《中国中西医结合杂志》 CAS CSCD 北大核心 1998年第3期162-164,共3页
目的 :探讨健脾益气方 (JPYQR)抑制胃粘膜损伤的作用机理。方法 :采用束缚水浸法造成大鼠急性胃粘膜损伤 ,测定溃疡指数 ,检测血浆及胃组织中热休克蛋白 (heatshockprotein ,HSP70 )的变化 ,并对胃组织细胞HSPs进行免疫组织化学研究。结... 目的 :探讨健脾益气方 (JPYQR)抑制胃粘膜损伤的作用机理。方法 :采用束缚水浸法造成大鼠急性胃粘膜损伤 ,测定溃疡指数 ,检测血浆及胃组织中热休克蛋白 (heatshockprotein ,HSP70 )的变化 ,并对胃组织细胞HSPs进行免疫组织化学研究。结果 :用中药JPYQR和西药丽珠得乐预处理的大鼠 ,溃疡指数小于模型组 (P <0 0 0 1 ) ,而JPYQR组又小于丽珠得乐组 (P <0 0 1 ) ;预处理两组血浆及胃组织中HSP70 水平相反明显高于模型组 (P <0 0 5 ) ,而JPYQR组血浆中HSP70 水平又显著高于丽珠得乐组 (P <0 0 5 ) ,二者胃组织中的HSP70 水平虽有差异 ,但无统计学意义 (P >0 0 5 ) ;免疫组织化学研究提示腺体表达大量HSP70 和HSP60 ,按模型组、丽珠得乐组、JPYQR组依次增强。结论 :中药健脾益气方能诱导大鼠提高HSPs的表达 ,防止胃粘膜损伤 ,HSPs可能介导胃粘膜防御。 展开更多
关键词 健脾益气方 热休克蛋白 胃粘膜损伤
下载PDF
健脾解毒方通过COX-2-Wnt/β-catenin信号通路抑制裸鼠人结肠癌血管新生 被引量:29
17
作者 刘宣 王炎 +4 位作者 隋华 殷佩浩 王一斐 范忠泽 李琦 《中华中医药杂志》 CAS CSCD 北大核心 2013年第5期1276-1280,共5页
目的:研究健脾解毒方对裸鼠人结肠癌血管新生的作用及机制。方法:建立人结肠癌HT-29细胞裸鼠皮下移植瘤模型,随机分为5组:对照组(0.9%氯化钠溶液组),健脾解毒方低、中、高剂量组(250、500、1 000mg·kg-1·d-1)和化疗药顺铂组(1... 目的:研究健脾解毒方对裸鼠人结肠癌血管新生的作用及机制。方法:建立人结肠癌HT-29细胞裸鼠皮下移植瘤模型,随机分为5组:对照组(0.9%氯化钠溶液组),健脾解毒方低、中、高剂量组(250、500、1 000mg·kg-1·d-1)和化疗药顺铂组(1mg·kg-1·d-1)。给药第21天,处死各组荷瘤鼠,比较各组肿瘤大小。免疫组化法检测各组瘤体的微血管密度(MVD)、COX-2和β-catenin表达;ELISA测定血清中血管内皮生长因子(VEGF)、血管生成素(Ang-2)和碱性成纤维细胞生长因子(bFGF)的表达。结果:健脾解毒方低、中、高剂量组的瘤重抑制率分别为30.14%、38.01%、40.36%。免疫组化结果显示,对照组、健脾解毒方低、中、高剂量组瘤体MVD计数分别为(56.00±2.65)、(43.00±1.58)、(28.67±2.53)和(23.33±2.08),与对照组比较差异显著(P<0.01)。ELISA结果显示,健脾解毒方能够显著下调裸鼠血清中VEGF、Ang-2和bFGF表达(P<0.01)。同时,健脾解毒方能够显著下调瘤体中COX-2和β-catenin蛋白表达,呈剂量依赖效应。结论:健脾解毒方能抑制人结肠癌皮下移植瘤的生长和血管新生,其机制可能通过COX-2-Wnt/β-catenin信号通路下调VEGF表达有关。 展开更多
关键词 健脾解毒方 结肠癌 血管新生 COX-2 WNT β-catenin
原文传递
健脾补肾方联合二甲双胍对肥胖型多囊卵巢综合征患者内分泌及生化指标的影响 被引量:29
18
作者 翟军 孙莹璞 《中国实验方剂学杂志》 CAS 北大核心 2011年第8期247-249,共3页
目的:观察健脾补肾方联合二甲双胍对肥胖型多囊卵巢综合征患者内分泌、生化指标的影响。方法:24例肥胖多囊卵巢综合征(PCOS)患者应用二甲双胍500 mg/次,3次/d,同时口服健脾补肾方每日1剂,早晚分服,共3月;20例肥胖PCOS患者单用二甲双胍50... 目的:观察健脾补肾方联合二甲双胍对肥胖型多囊卵巢综合征患者内分泌、生化指标的影响。方法:24例肥胖多囊卵巢综合征(PCOS)患者应用二甲双胍500 mg/次,3次/d,同时口服健脾补肾方每日1剂,早晚分服,共3月;20例肥胖PCOS患者单用二甲双胍500 mg/次,3次/d,连续3个月。比较治疗前后临床症状,内分泌和生化指标的改变。结果:治疗后中西医结合组中14例患者恢复了月经,西药组中11例患者恢复了月经。2组患者治疗前后腰臀比(WHR)、促黄体生成素(LH),雄激素(T),空腹胰岛素(FINS),胰岛素曲线下面积(IAUC)明显降低,ISI明显的提高,有显著性差异(P<0.05)。在血脂改善方面,中西医结合组患者治疗后,甘油三酯,低密度脂蛋,载脂蛋白B均明显下降(P<0.05~P<0.01);二甲双胍组患者血脂无明显改变。结论:健脾补肾方联合二甲双胍可明显降低肥胖型多囊卵巢综合征患者LH,T水平,提高胰岛素的敏感性,降低血脂水平,减少二甲双胍副作用,提高患者依从性,尤其是对血脂的改善明显优于单用二甲双胍组。 展开更多
关键词 多囊卵巢综合征 二甲双胍 健脾补肾方
原文传递
健脾养胃方加减对胃癌化疗患者肠道菌群的影响 被引量:28
19
作者 吴娟 滕钰浩 +3 位作者 董伟 王瑞平 詹瑧 张军峰 《中医杂志》 CSCD 北大核心 2019年第6期497-502,共6页
目的探讨健脾养胃方加减辅助胃癌化疗的肠道微生态学机制。方法根据临床意愿将90例胃癌患者分为观察组51例和化疗组39例,另设63例健康体检者作为对照组。化疗组按照美国国立综合癌症网络(NCCN)指南标准化疗方案进行化疗,观察组在化疗组... 目的探讨健脾养胃方加减辅助胃癌化疗的肠道微生态学机制。方法根据临床意愿将90例胃癌患者分为观察组51例和化疗组39例,另设63例健康体检者作为对照组。化疗组按照美国国立综合癌症网络(NCCN)指南标准化疗方案进行化疗,观察组在化疗组的基础上给予健脾养胃方加减口服,每日1剂。两组均治疗3个月,并完成3次化疗。治疗前后进行生活质量评分,治疗后基于16S rRNA基因进行高通量测序粪便菌群。结果观察组治疗后生活质量评分降低(P <0. 05),化疗组治疗后生活质量评分差异无统计学意义(P> 0. 05),且观察组治疗后生活质量评分显著低于化疗组(P <0. 05)。各组肠道菌群多样性差异无统计学意义(P> 0. 05)。化疗组肠道菌群Chao和Ace显著低于对照组(P <0. 05),观察组肠道菌群Chao和Ace显著高于化疗组(P <0. 05)。与化疗组比较,观察组共生菌门相对丰度显著降低(P <0. 05)。与对照组比较,观察组和化疗组梭菌目、反刍球菌科、普雷沃菌属7、反刍球菌属的相对丰度均显著下降(P <0. 05或P <0. 01),而脱硫弧菌目、共生菌目、脱硫弧菌科、共生菌科、锥杆菌属的相对丰度均显著升高(P <0. 01);与化疗组比较,观察组共生菌目、共生菌科、反刍球菌属、毛螺菌科NK4A136组、锥杆菌属的相对丰度均显著下降(P <0. 05),而毛螺菌科NK4A136组的相对丰度显著升高(P <0. 05)。结论健脾养胃方加减能够逆转胃癌患者化疗导致的肠道菌群变化,从而提高患者生活质量。 展开更多
关键词 胃癌 健脾养胃方加减 化疗 肠道菌群 生活质量
原文传递
补肾健脾方及其拆方对移植性原发性肝癌小鼠肿瘤生长的影响及差异研究 被引量:26
20
作者 钟薏 罗春蕾 +3 位作者 张安君 赵喜 周荣耀 刘慧 《中国中西医结合杂志》 CAS CSCD 北大核心 2011年第2期213-217,共5页
目的探讨补肾健脾方及其拆方对移植性原发性肝癌小鼠肿瘤生长的影响及差异。方法 50只荷移植性原发性肝癌小鼠随机分为模型组、补肾健脾组、补肾组、健脾组及5-FU(5-氟尿嘧啶)组,每组10只。模型组和各中药组小鼠分别给予蒸馏水和相应中... 目的探讨补肾健脾方及其拆方对移植性原发性肝癌小鼠肿瘤生长的影响及差异。方法 50只荷移植性原发性肝癌小鼠随机分为模型组、补肾健脾组、补肾组、健脾组及5-FU(5-氟尿嘧啶)组,每组10只。模型组和各中药组小鼠分别给予蒸馏水和相应中药方灌胃,每天1次,连续给药10天;5-FU组隔天给予5-FU腹腔注射。观察各组小鼠的体重、瘤重、表观扩散系数(apparentdiffusion coefficien,t ADC)、血清血管内皮生长因子(vascular endothelial growth factor,VEGF)、肿瘤细胞凋亡及细胞周期。结果各治疗组中,小鼠体重和去瘤体重比较,补肾健脾组高于其他各组(P<0.01,P<0.05);肿瘤指数比较,补肾健脾组低于其他各组(P<0.05);肿瘤ADC比较,补肾健脾组、5-FU组均低于补肾组和健脾组(P<0.05);血清VEGF及肿瘤瘤重比较,5-FU组低于各中药组(P<0.01,P<0.05),补肾组、补肾健脾组低于健脾组(P<0.05);抑瘤率及细胞凋亡比较,5-FU组最高,补肾健脾组次之;各组S期细胞比较,5-FU组低于各中药组(P<0.01,P<0.05),补肾健脾组显著低于补肾组和健脾组(P<0.01);G0-G1期比较,健脾组低于5-FU组(P<0.01),高于补肾组和补肾健脾组(P<0.05)。G2-M期各组比较差异无统计学意义。结论补肾健脾方及其拆方对小鼠移植性原发性肝癌的作用机制在于抑制血清VEGF的表达,促进肿瘤细胞的凋亡;MRI弥散技术ADC值的变化与VEGF和细胞凋亡同步,能客观反应肿瘤细胞代谢,是评定中药疗效的新型手段。 展开更多
关键词 补肾健脾方 拆方 表观扩散系数 血管内皮生长因子 细胞凋亡
下载PDF
上一页 1 2 22 下一页 到第
使用帮助 返回顶部